Skip to content

Morphological and functional assessment of diabetic cardiomyopathy

Morphological and functional assessment of diabetic cardiomyopathy - Evaluation of pathogenesis of diabetic cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012756
Enrollment
20
Registered
2014-01-06
Start date
2013-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic cardiomyopaty and diabetes with normal cardiac function as controls

Interventions

None listed

Sponsors

Tokyo Women's Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diabetic patients who are followed up in diabetic center or Heart center in Tokyo Women's medical university. Inclusion criteria is normal cardiac function and no coronary stenosis in diabetic controls, and low LVEF< 45 % and no coronary stenosis in DMCM.

Exclusion criteria

Exclusion criteria: Severe renal dysfunction (CKD stage>=4) Patients with other multiple complication who are unlikely to undergo proposed examinations.

Design outcomes

Primary

MeasureTime frame
We analyze difference in myocardial blood flow (MBF) at rest and stress, and myocardial flow reserve (MFR) as determined by ammonia-13 PET, cardiac function and size of LGE as determined by cardiac MRI between patients with DMCM and diabetes control.

Secondary

MeasureTime frame
We analyze relationship between coronary calcification and MBF and MFR. In diabetes controls, we compare the MBF and MFR with clinical characteristics such as HbA1c, fasting glucose, plasma cholesterol and diabetic history.

Countries

Japan

Contacts

Public ContactMitsuru Momose

Tokyo Women's Medical University Dept.of Diagnostic Imaging and Nuclear Medicine

momose.mitsuru@twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026